About i-Optics
i-Optics is a company based in Rijswijk (Netherlands) founded in 2006. It operates as a B2B. i-Optics has raised $36.4 million across 4 funding rounds from investors including NIBC, Aescap and HBM Partners. i-Optics operates in a competitive market with competitors including Sensimed, Implandata, Inoveon, Azul Optics and Diopsys, among others.
- Headquarter Rijswijk, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$36.4 M (USD)
in 4 rounds
-
Latest Funding Round
$15.24 M (USD), Series E
May 22, 2015
-
Investors
NIBC
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of i-Optics
i-Optics has successfully raised a total of $36.4M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $15.24 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in i-Optics
i-Optics has secured backing from 6 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include NIBC, Aescap and HBM Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Aescap is focused on investing in high-growth biotech companies.
|
Locked | Locked | Locked | |
|
Late-stage life sciences investments are managed via VC and PE.
|
Locked | Locked | Locked | |
|
De Hoge Dennen is engaged in Dutch retail real estate investment.
|
Locked | Locked | Locked |
Investor details for i-Optics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by i-Optics
Investment portfolio details for i-Optics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - i-Optics
Detailed financials for i-Optics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
I-Optics Comparisons
Peer comparison for i-Optics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of i-Optics
i-Optics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, Implandata, Inoveon, Azul Optics and Diopsys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A contact lens-based platform for glaucoma monitoring is offered.
|
|
| Locked | Locked | Locked |
Intraocular pressure is monitored continuously via an implantable microsensor.
|
|
| Locked | Locked | Locked |
Eye disease detection services including diabetic retinopathy are provided.
|
|
| Locked | Locked | Locked |
Device for assessing the eye health against damaging light
|
|
| Locked | Locked | Locked |
Non-invasive visual electrophysiology devices are supplied for ophthalmological diagnosis.
|
Detailed competitors of i-Optics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on I-Optics
Complete news archive for i-Optics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about i-Optics
i-Optics was founded in 2006 and raised its 1st funding round 4 years after it was founded.
i-Optics is headquartered in Rijswijk, Netherlands. It is registered at Rijswijk, South Holland, Netherlands.
i-Optics is a funded company, having raised a total of $36.4M across 4 funding rounds to date.
i-Optics, backed by 36401260.0 from Aescap, HBM Partners, De Hoge Dennen Capital, NIBC, HealthCrest, Jeroen Cammeraat, focuses on providing healthcare solutions, developing medical devices, diagnostic imaging, and eye care systems. i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals. Driving innovation, growth, and excellence in its industry sectors.
i-Optics's top competitors include 2EyesVision, Sensimed and Diopsys.
i-Optics has 6 investors. Key investors include NIBC, Aescap, HBM Partners, De Hoge Dennen, and HealthCrest.